Strategy for pancreatic cancer uses engineered exosomes targeting mutated KRAS gene

PRECEDE study points to screening method for pancreatic cancer

Research published in April in the Journal of the National Comprehensive Cancer Network showcases the feasibility of improving early detection and prevention for pancreatic cancer.

April 19, 2024

Vol.50 No.16

In Brief

Anna Berkenblit named chief scientific and medical officer of PanCAN

Anna Berkenblit, a clinical oncologist and drug developer, was named the first-ever chief scientific and medical officer of the Pancreatic Cancer Action Network.

April 05, 2024

Vol.50 No.14

In Brief

Diane Simeone begins work as director of Moores Cancer Center on April 1

Diane M. Simeone will become director of Moores Cancer Center at UC San Diego Health effective April 1.

March 08, 2024

Vol.50 No.10

In Brief

Tampa General Hospital Cancer Institute earns National Pancreas Foundation designation

Tampa General Hospital was named an approved Center of Excellence facility for pancreatic cancer treatment by the National Pancreas Foundation.

February 23, 2024

Vol.50 No.08

Drugs & Targets

FDA approves Onivyde for first-line treatment of metastatic pancreatic adenocarcinoma

FDA has approved Onivyde (irinotecan liposome) with oxaliplatin, fluorouracil, and leucovorin, for the first-line treatment of metastatic pancreatic adenocarcinoma.

February 16, 2024

Vol.50 No.07

In Brief

Edna Cukierman named Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research at Fox Chase

Edna “Eti” Cukierman was named the newly created Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research at Fox Chase Cancer Center.

December 15, 2023

Vol.49 No.46

Strategy for pancreatic cancer uses engineered exosomes targeting mutated KRAS gene

YOU MAY BE INTERESTED IN

PRECEDE study points to screening method for pancreatic cancer

Anna Berkenblit named chief scientific and medical officer of PanCAN

Diane Simeone begins work as director of Moores Cancer Center on April 1

Tampa General Hospital Cancer Institute earns National Pancreas Foundation designation

FDA approves Onivyde for first-line treatment of metastatic pancreatic adenocarcinoma

Edna Cukierman named Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research at Fox Chase

Renew today!

Subscriber content

Login